# A breakthrough pancreatic cancer drug won approval. They still struggle to access it

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-08 19:29 UTC · Category: Health · Sources: 1 · Current Velocity: 0.25

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Oncodaily | David Gandara: Daraxonrasib Marks a Major Advance in Pancreatic Cancer Care | 2026-09-08 08:31 | [Source Link](https://news.google.com/rss/articles/CBMid0FVX3lxTE1hNEZRbDhZdk1Mb293TFFLRFhkazlZVnBxN0pIY3FrS0c3VzJKYmFTbWpYMUNNb2YwTDBBdWZ6U3VJUG9TR1k1Q2pCeERNZ0VzVFdqbnF3NjAzaFBJZUVYYXo5YWpCc0VnZ1dZMDB3MWVLcDRaSFh3?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-08/a-breakthrough-pancreatic-cancer-drug-won-approval-they-still-struggle-to*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*
